Neuroimaging, biomarkers, and management of dementia with lewy bodies

Review

. 2013 Oct 7:4:151.

doi: 10.3389/fneur.2013.00151.

Affiliations

Review

Hasmet A Hanagasi et al. Front Neurol. 2013.

. 2013 Oct 7:4:151.

doi: 10.3389/fneur.2013.00151.

¹ Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University , Istanbul, Turkey.

No abstract available

Keywords: Lewy bodies; Lewy body disease; biomarkers; dementia; magnetic resonance imaging.

Cited by

Biomarkers in Alzheimer's, Frontotemporal, Lewy Body, and Vascular Dementias.
Koenig AM, Nobuhara CK, Williams VJ, Arnold SE. Koenig AM, et al. Focus (Am Psychiatr Publ). 2018 Apr;16(2):164-172. doi: 10.1176/appi.focus.20170048. Epub 2018 Apr 27. Focus (Am Psychiatr Publ). 2018. PMID: 31975911 Free PMC article. Review.
Biomarkers for the diagnosis of Alzheimer's disease, dementia Lewy body, frontotemporal dementia and vascular dementia.
Maclin JMA, Wang T, Xiao S. Maclin JMA, et al. Gen Psychiatr. 2019 Feb 23;32(1):e100054. doi: 10.1136/gpsych-2019-100054. eCollection 2019. Gen Psychiatr. 2019. PMID: 31179427 Free PMC article.
Neurophysiological biomarkers for Lewy body dementias.
Cromarty RA, Elder GJ, Graziadio S, Baker M, Bonanni L, Onofrj M, O'Brien JT, Taylor JP. Cromarty RA, et al. Clin Neurophysiol. 2016 Jan;127(1):349-359. doi: 10.1016/j.clinph.2015.06.020. Epub 2015 Jun 27. Clin Neurophysiol. 2016. PMID: 26183755 Free PMC article. Review.
Genetic markers in biological fluids for aging-related major neurocognitive disorder.
Castro-Chavira SA, Fernandez T, Nicolini H, Diaz-Cintra S, Prado-Alcala RA. Castro-Chavira SA, et al. Curr Alzheimer Res. 2015;12(3):200-9. doi: 10.2174/1567205012666150302155138. Curr Alzheimer Res. 2015. PMID: 25731625 Free PMC article. Review.

1. Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain (2009) 132:195–20310.1093/brain/awn298 - DOI - PubMed
1. Sabattoli F, Boccardi M, Galluzzi S, Treves A, Thompson PM, Frisoni GB. Hippocampal shape differences in dementia with Lewy bodies. Neuroimage (2008) 41:699–70510.1016/j.neuroimage.2008.02.060 - DOI - PubMed
1. Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O’Brien JT. Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiol Aging (2012) 33:1228–3610.1016/j.neurobiolaging.2010.12.015 - DOI - PubMed
1. Kantarci K, Ferman TJ, Boeve BF, Weigand SD, Przybelski S, Vemuri P, et al. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology (2012) 79:553–6010.1212/WNL.0b013e31826357a5 - DOI - PMC - PubMed
1. O’Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology (2001) 56:1386–810.1212/WNL.56.10.1386 - DOI - PubMed